MTOR and neoplasm: This approach is made possible by studies performed over the last twenty years that have characterised the association between cellular metabolism and T-cell effector function and differentiation and revealed the metabolic competition within the TME between tumour cells and T-cells exemplified by the study of AMPK, mTOR, glutamine blockade, L-arginine levels, supplementation with NAD+, and Methionine restriction.